No headlines found.
No press releases found.
No news found.
The First Trust Emerging Markets AlphaDEX Fund is an exchange-traded fund. The investment objective of the Fund is to seek investment results that correspond generally to the price and yield, before the Funds fees and expenses, of an equity index called the NASDAQ AlphaDEX Emerging Markets Index. The NASDAQ AlphaDEX Emerging Markets Index employs the AlphaDEX stock selection methodology to select stocks from the NASDAQ Emerging Markets Index. The Index is constructed by ranking the stocks in the NASDAQ Emerging Markets index on growth factors including 3-, 6- and 12-month price appreciation, sales to price and one year sales growth and separately on value factors including book value to price, cash flow to price and return on assets.
First Trust Emerging Markets Alphadex trades on the NASDAQ stock market under the symbol FEM.
As of March 5, 2026, FEM stock price declined to $29.75 with 155,615 million shares trading.
FEM has a beta of 0.55, meaning it tends to be less sensitive to market movements. FEM has a correlation of 0.35 to the broad based SPY ETF.
FEM has a market cap of $618.70 million. This is considered a Small Cap stock.
In the last 3 years, FEM traded as high as $32.98 and as low as $19.62.
FEM has outperformed the market in the last year with a return of +36.7%, while the SPY ETF gained +19.4%. In the last 3 month period, FEM beat the market returning +10.4%, while SPY returned -0.2%. However, in the most recent 2 weeks FEM has underperformed the stock market by returning -3.0%, while SPY returned -0.7%.
FEM support price is $29.84 and resistance is $30.60 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that FEM shares will trade within this expected range on the day.
